The inaugural global Mitochondrial Health Summit has marked a milestone for healthcare, positioning mitochondrial health at the forefront of the growing movement: advancing healthspan through science beginning at the cellular level.
Held in Sydney on 26 June, with a simultaneous satellite event in Kuala Lumpur, the Summit attracted more than 250 delegates from complementary medicine, nutrition, pharmacy, education and research, reflecting growing interest in the role of mitochondrial function in lifelong health.
The Summit arrives at a pivotal moment for healthcare. As populations worldwide seek healthy ageing strategies, the conversation is shifting upstream towards the biological mechanisms underpinning health.
At the centre of that conversation are the mitochondria – the body’s “cellular powerhouses,” which generate the energy required for organs, tissues and biological systems to function effectively.
Mitochondrial health is supported by Ubiquinol, a naturally occurring, lipid-soluble antioxidant that helps to reduce cellular damage and supports well-being from preconception to ageing, including cardiovascular health, cognition, women’s health, energy levels and general health.
However, Ubiquinol levels decline naturally from the age of 20 onwards.
During presentations spanning cardiology, reproductive health, women's health, complementary medicine, pharmacy and nutrition, a common theme emerged: the future of healthcare will be shaped by our understanding of subcellular health.
"For more than four decades, Kaneka has invested in advancing mitochondrial health science because we believe it sits at the very core of human wellbeing,” says Tsuyoshi Takakuwa, Head of Marketing and Sales Team (APAC), Supplemental Nutrition Business Division, Kaneka Corporation.
"We believe the age of “mitoceuticals” has arrived. Mitochondrial health will become one of the defining healthcare conversations of the next decade", added Takakuwa.
As the underwriting sponsor of the Summit, Kaneka Ubiquinol further strengthened its position at the forefront of the mitochondrial health sector.
Key highlights
The upstream shift: Across cardiology, women’s health, reproductive health and healthy ageing, a recurring theme was the growing scientific interest in the role of mitochondrial function as foundational across multiple areas of health.
Research is contributing to the understanding of how mitochondrial biology may be involved in physiological pathways, supporting ongoing investigation into its relevance for clinical practice.
The gut-mitochondria axis: Preliminary evidence suggests the intricate communication between the gut microbiome and mitochondrial function, revealing potential implications for metabolic health, immune regulation, inflammation and energy production.
The Age of Mitoceuticals: Nutrients key to mitochondrial energy production, including Ubiquinol, were acknowledged as foundational components of healthspan strategies for mitochondrial support, vitality, resilience and healthy ageing through targeted nutritional and clinical approaches.
Dr Kazunori Hosoe, PhD, Chief Scientist at Kaneka Ubiquinol, was recognised with a Lifetime Scientific Excellence in Ubiquinol Research award for 50-plus years of CoQ10 and Ubiquinol research.
His contributions have helped to establish a scientific foundation that continues to shape mitochondrial research and clinical practice globally.
